PT-141
Bremelanotide, a peptide acting on melanocortin receptors.
Shop
Bremelanotide, a peptide acting on melanocortin receptors.
A peptide hormone involved in oxytocin receptor signalling.
A no-DAC GHRH analogue commonly described as modified GRF 1-29.
A growth-hormone-releasing hormone analogue with a drug affinity complex.
Human chorionic gonadotropin, a glycoprotein hormone.
A modified insulin-like growth factor studied in growth signalling.
A GHRH analogue investigated in hormonal signalling and visceral fat biology.
A growth-hormone secretagogue studied through the ghrelin receptor pathway.
A short kisspeptin sequence studied in reproductive hormone signalling.
An early growth-hormone secretagogue studied in endocrine and appetite signalling.
Vasoactive intestinal peptide, a neuroendocrine signalling peptide.
A 191-amino-acid growth-hormone protein, not a short peptide fragment.
A synthetic growth-hormone secretagogue studied in endocrine signalling.
A GHRH analogue investigated in pituitary growth-hormone responses.
A GLP-1 receptor agonist studied in metabolic regulation.
A dual GIP and GLP-1 receptor agonist studied in metabolic regulation.
A research peptide acting at three receptors involved in metabolic signalling.
A modified growth-hormone fragment investigated in lipid metabolism.
A small-molecule NNMT inhibitor. It is not a peptide.
A metabolic compound involved in fatty-acid transport; not a peptide.
A long-acting amylin analogue studied in metabolic signalling.
A small-molecule estrogen-related receptor agonist; not a peptide.
A dual glucagon and GLP-1 receptor agonist studied in metabolism.
A dual GLP-1 and glucagon receptor agonist studied in metabolism.
A synthetic tetrapeptide, also called Epitalon, studied in cellular aging models.
A mitochondrial-derived peptide investigated in cellular energy regulation.
A tripeptide involved in cellular redox chemistry.
An essential cellular coenzyme rather than a peptide.
A synthetic peptide studied in tissue-injury and repair models.
A research name associated with thymosin beta-4-related peptides.
Cibinetide, an erythropoietin-derived peptide studied in tissue-protective signalling.
An immune-modulating peptide studied in T-cell and host-response biology.
A three-amino-acid fragment associated with alpha-melanocyte-stimulating hormone.
A human cathelicidin-related peptide studied in host-defence biology.
A thymus-derived peptide preparation investigated in immune research.
Delta sleep-inducing peptide, studied in sleep and neuroendocrine research.
A tuftsin-derived peptide investigated in stress-response research.
A peptide investigated in neurotrophic signalling and neurological research.
A supplier-designated peptide preparation associated with neurological research.
The Glu-Asp-Arg tripeptide associated with experimental neurological research.
A two-component blend; the selected variant specifies each component amount.
A 5 + 5 mg blend of a no-DAC GHRH analogue and ipamorelin.
A four-component blend containing 10 + 50 + 10 + 10 mg in the named order.
A three-component blend with a 10 + 50 + 10 mg composition.
Supplier-designated Lipo-C mixture with B vitamins.
Supplier-designated Lipo-C mixture without B vitamins.
A blend of an amylin analogue and a GLP-1 receptor agonist.
A proprietary supplier-labelled mixture with unconfirmed ingredients.
A copper-binding tripeptide investigated in extracellular matrix and skin biology.
A melanocortin receptor agonist associated with pigmentation research.
Melanotan I (MT1), also known as afamelanotide, is an alpha-MSH analogue associated with pigmentation research.
Supplier-listed water with 0.9% benzyl alcohol, supplied in 3 mL and 10 mL vials.
Supplier-listed aqueous acetic acid preparation, supplied in 3 mL and 10 mL vials.
Supplier-listed bacteriostatic water in a 10 mL vial.
For in-vitro laboratory research only. Not for human or veterinary use.